白介素-10与心血管疾病的关系被引量：9

暂未订购

导出

摘要白介素-10是一种多细胞源性和多功能的细胞因子,其主要作用是参与炎症反应和免疫反应,调节细胞的生长与分化。近年的研究表明,白介素-10与部分心血管疾病的关系密切,该文就这方面的内容作一综述,供临床参考。

作者孙芳毅王书彩郭丽敏

机构地区河北医科大学第四医院心内科

出处《新医学》北大核心 2007年第8期557-558,共2页 Journal of New Medicine

关键词白介素-10 急性冠状动脉综合征细胞因子经皮冠状动脉介入治疗心肌缺血

分类号 R54 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献8

1PASQUI A L,DI RENZO M,BOVA G,et al.Pro-inflammatory/anti-inflammatory cytokine imbalance in acute coronary syndromes[J].Clin Exp Med,2006,6(1):38-44.
2HEESCHEN C,DIMMELER S,HAMM C W,et al.Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes[J].Circulation,2003,107(16):2109-2114.
3陈燕,常志文.冠心病患者血中白介素-6和白介素-10浓度的变化──附46例检测报告[J].新医学,2004,35(7):413-414. 被引量：20
4CALIGIURI G,RUDLING M,OLLIVIER V,et al.Interleukin-10 deficiency increases atherosclerosis,thrombosis,and low-density lipoproteins in apolipoprotein E knockout mice[J].Mol Med,2003,9(1-2):10-17.
5WAEHRE T,HALVORSEN B,DAMAS J K,et al.Inflammatory imbalance between IL-10 and TNFalpha in unstable angina potential plaque stabilizing effects of IL-10[J].Eur J Clin Invest,2002,32(11):803-810.
6洪梅,魏文宁,杨锐,杨焰,宋善俊.IL-10对IL-6诱导外周血单个核细胞组织因子表达的调节作用[J].中国实验血液学杂志,2005,13(3):479-482. 被引量：11
7褚松筠,丁文惠,胡春阳,蔡大勇,马铁民,唐朝枢.白细胞介素10在心肌缺血再灌注损伤中对细胞凋亡的作用及机制研究[J].中华老年心脑血管病杂志,2006,8(6):404-407. 被引量：14
8FELDMAN L J,AGUIRRE L,ZIOL M,et al.Interleukin-10 inhibits intimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits[J].Circulation,2000,101(8):908-916.

二级参考文献18

1Mazzone A, S. De Servi, Mazzucchelli I, et al. Increased concentrations of inflammatory mediators in unstable angina: correlation with serum troponin T. Heart. 2001 , 85 : 571 -575.
2Danesh J, Collins R, Appteby P, et al. Association of fibrinogen,C-reactive protein, albumin or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA. 1998 , 279 :1477 - 1482.
3Edwords RL, Rickles FR. The role of leukocytes in the activation of blood coagulaition. Semi. Hematol. 1992, 29:202 -212.
4Osterud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coagul Fibrinolysis. 1995 , 6( Suppl 1 ) :S20 -25.
5Uyemura K,Demer LL,Castle SC,et al.Cross regulatory roles of Interleukin(IL).12 and IL-10 in atherosclerosis.J Clin Invest.1996,97:2130—2138.
6Mallat Z, Heymes C, Ohan J, et al. Expression of Interleukin-10 in advanced human atherosclerotic plagues. Arterioscler Thromb Vasc Boil. 1999, 19:611 -616.
7de Vries JE. Immunosuppressive and anti-inflammatory properities of interleukin-10. Ann Med. 1995, 27:537 -541.
8Pinderski Oslund LJ, Hedrick CC, Olvera T, et al. Interleukin-10 blocks atherosclerotic evens in vitro and in vivo. Arterioscler Thromb Vasc Biol. 1999, 19:2847-2853.
9Lee JC, Kumar S, Griswold DE, et al. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology. 2000, 47:185- 201.
10Yamamoto Y and Gaynor RB. Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer.J Clin Invest. 2001 , 107 : 135 - 142.